Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 299

1.

Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years.

Sheth VS, Potter V, Gandhi SA, Kulasekararaj AG, de Lavallade H, Muus P, Pagliuca A, Rice CFM, Mehra V, Grimaldi F, Inam S, Barber LD, Mufti GJ, Marsh JC.

Blood Adv. 2019 Oct 22;3(20):3070-3079. doi: 10.1182/bloodadvances.2019000480.

PMID:
31648330
2.

Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia: a joint study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood and Marrow Transplantation (EBMT).

Miller PDE, Snowden JA, De Latour RP, Iacobelli S, Eikema DJ, Knol C, Marsh JCW, Rice C, Koh M, Fagioli F, Chaganti S, Finke J, Duarte RF, Bader P, Farge D, Passweg JR, Madrigal JA, Dufour C.

Bone Marrow Transplant. 2019 Sep 25. doi: 10.1038/s41409-019-0680-4. [Epub ahead of print]

3.

Allogeneic stem cell transplantation for acquired pure red cell aplasia.

Halkes C, de Wreede LC, Knol C, Simand C, Aljurf M, Tbakhi A, Vazquez L, Bloor A, Wagner-Drouet E, Vural F, Bodova I, Isaksson C, Diaz MÁ, Gruhn B, Snowden J, Arat M, Bazarbachi A, Spilleboudt C, Kulagin A, Marsh JC, Passweg J, Risitano AM, Peffault de Latour R, Dufour C; European Society for Blood and Marrow Transplantation Severe Aplastic Anemia Working Party.

Am J Hematol. 2019 Nov;94(11):E294-E296. doi: 10.1002/ajh.25609. Epub 2019 Sep 9. No abstract available.

PMID:
31396977
4.

Impact of Human Leucocyte Antigen epitope matched platelet transfusions in alloimmunised aplastic anaemia patients.

Kallon D, Navarrete CV, Sage DA, Stanworth S, Mufti GJ, Marsh JCW, Brown CJ.

Transfus Med. 2019 Jun 17. doi: 10.1111/tme.12612. [Epub ahead of print]

PMID:
31209973
5.

Remission of inflammatory bowel disease in Glucose-6-Phosphatase 3 deficiency by allogeneic haematopoietic stem cell transplantation.

Bolton C, Burch N, Morgan J, Harrison B, Pandey S, Pagnamenta AT, Taylor JC, Taylor JM, Marsh JCW, Potter V, Travis S, Uhlig HH; Oxford IBD cohort investigators.

J Crohns Colitis. 2019 Jun 3. pii: jjz112. doi: 10.1093/ecco-jcc/jjz112. [Epub ahead of print]

PMID:
31157858
6.

The Case for Upfront HLA-Matched Unrelated Donor Hematopoietic Stem Cell Transplantation as a Curative Option for Adult Acquired Severe Aplastic Anemia.

Marsh JCW, Risitano AM, Mufti GJ.

Biol Blood Marrow Transplant. 2019 Sep;25(9):e277-e284. doi: 10.1016/j.bbmt.2019.05.012. Epub 2019 May 24. Review.

PMID:
31129354
7.

Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome.

Bono E, McLornan D, Travaglino E, Gandhi S, Gallì A, Khan AA, Kulasekararaj AG, Boveri E, Raj K, Elena C, Ireland RM, Bianchessi A, Jiang J, Todisco G, Ferretti VV, Cazzola M, Marsh JCW, Malcovati L, Mufti GJ.

Leukemia. 2019 Oct;33(10):2495-2505. doi: 10.1038/s41375-019-0457-1. Epub 2019 Apr 2.

PMID:
30940907
8.

Novel ADA2 mutation presenting with neutropenia, lymphopenia and bone marrow failure in patients with deficiency in adenosine deaminase 2 (DADA2).

Ghurye RR, Sundaram K, Smith F, Clark B, Simpson MA, Fairbanks L, Adhya Z, Mufti GJ, Marsh JCW, Ibrahim MAA.

Br J Haematol. 2019 Aug;186(3):e60-e64. doi: 10.1111/bjh.15896. Epub 2019 Mar 28. No abstract available.

PMID:
30924144
9.

Clinical and morphological predictors of outcome in older aplastic anemia patients treated with eltrombopag.

Fattizzo B, Kulasekararaj AG, Hill A, Benson-Quarm N, Griffin M, Munir T, Arnold L, Riley K, Ireland R, De Lavallade H, Potter V, Consonni D, Hillmen P, Mufti GJ, Barcellini W, Marsh JCW.

Haematologica. 2019 Nov;104(11):e494-e496. doi: 10.3324/haematol.2019.216374. Epub 2019 Mar 19. No abstract available.

10.

Allogeneic Hematopoietic Cell Transplantation in Patients Aged 50Years or Older with Severe Aplastic Anemia.

Rice C, Eikema DJ, Marsh JCW, Knol C, Hebert K, Putter H, Peterson E, Deeg HJ, Halkes S, Pidala J, Anderlini P, Tischer J, Kroger N, McDonald A, Antin JH, Schaap NP, Hallek M, Einsele H, Mathews V, Kapoor N, Boelens JJ, Mufti GJ, Potter V, Pefault de la Tour R, Eapen M, Dufour C.

Biol Blood Marrow Transplant. 2019 Mar;25(3):488-495. doi: 10.1016/j.bbmt.2018.08.029. Epub 2018 Sep 5.

PMID:
30194027
11.

Somatic Mutations in Aplastic Anemia.

Mufti GJ, Marsh JCW.

Hematol Oncol Clin North Am. 2018 Aug;32(4):595-607. doi: 10.1016/j.hoc.2018.03.002. Epub 2018 Jun 5. Review.

PMID:
30047413
12.

What do women want? Women want services tailored to their needs.

Marsh JC.

Addiction. 2018 Jun;113(6):999-1000. doi: 10.1111/add.14203. Epub 2018 Mar 26. No abstract available.

PMID:
29582504
13.

Gender differences in trends for heroin use and nonmedical prescription opioid use, 2007-2014.

Marsh JC, Park K, Lin YA, Bersamira C.

J Subst Abuse Treat. 2018 Apr;87:79-85. doi: 10.1016/j.jsat.2018.01.001. Epub 2018 Jan 5.

PMID:
29433788
14.

Isomer depletion as experimental evidence of nuclear excitation by electron capture.

Chiara CJ, Carroll JJ, Carpenter MP, Greene JP, Hartley DJ, Janssens RVF, Lane GJ, Marsh JC, Matters DA, Polasik M, Rzadkiewicz J, Seweryniak D, Zhu S, Bottoni S, Hayes AB, Karamian SA.

Nature. 2018 Feb 7;554(7691):216-218. doi: 10.1038/nature25483.

PMID:
29420479
15.

Heterozygous RTEL1 variants in bone marrow failure and myeloid neoplasms.

Marsh JCW, Gutierrez-Rodrigues F, Cooper J, Jiang J, Gandhi S, Kajigaya S, Feng X, Ibanez MDPF, Donaires FS, Lopes da Silva JP, Li Z, Das S, Ibanez M, Smith AE, Lea N, Best S, Ireland R, Kulasekararaj AG, McLornan DP, Pagliuca A, Callebaut I, Young NS, Calado RT, Townsley DM, Mufti GJ.

Blood Adv. 2018 Jan 4;2(1):36-48. doi: 10.1182/bloodadvances.2017008110. eCollection 2018 Jan 9.

16.

Drug use among Asian Americans: Differentiating use by acculturation status and gender.

Bersamira CS, Lin YA, Park K, Marsh JC.

J Subst Abuse Treat. 2017 Aug;79:76-81. doi: 10.1016/j.jsat.2017.06.002. Epub 2017 Jun 7.

PMID:
28673532
17.

British Committee for Standards in Haematology guidelines for aplastic anemia: Single centre retrospective review finds no compelling evidence for the recommended higher platelet count threshold of 20 × 109 /L - RESPONSE to Yan et al.

Killick SB, Bown N, Cavenagh J, Dokal I, Foukaneli T, Hillmen P, Ireland R, Kulasekararaj A, Mufti G, Snowden JA, Samarasinghe S, Wood A, Marsh JCW; British Society for Standards in Haematology AA Guidelines Committee.

Br J Haematol. 2018 Jul;182(2):286-287. doi: 10.1111/bjh.14766. Epub 2017 May 23. No abstract available.

PMID:
28542907
18.

Mixed T Cell Chimerism After Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Using an Alemtuzumab-Containing Regimen Is Shaped by Persistence of Recipient CD8 T Cells.

Grimaldi F, Potter V, Perez-Abellan P, Veluchamy JP, Atif M, Grain R, Sen M, Best S, Lea N, Rice C, Pagliuca A, Mufti GJ, Marsh JCW, Barber LD.

Biol Blood Marrow Transplant. 2017 Feb;23(2):293-299. doi: 10.1016/j.bbmt.2016.11.003. Epub 2016 Nov 2.

19.

Spontaneous myonecrosis in chronic myeloid leukaemia.

Renshaw H, Gandhi S, Shah A, Ireland R, Marsh JC, Mufti GJ.

Br J Haematol. 2016 Oct;175(2):190. doi: 10.1111/bjh.14278. Epub 2016 Aug 12. No abstract available.

PMID:
27514928
20.

Deep phenotyping of Tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment.

Kordasti S, Costantini B, Seidl T, Perez Abellan P, Martinez Llordella M, McLornan D, Diggins KE, Kulasekararaj A, Benfatto C, Feng X, Smith A, Mian SA, Melchiotti R, de Rinaldis E, Ellis R, Petrov N, Povoleri GA, Chung SS, Thomas NS, Farzaneh F, Irish JM, Heck S, Young NS, Marsh JC, Mufti GJ.

Blood. 2016 Sep 1;128(9):1193-205. doi: 10.1182/blood-2016-03-703702. Epub 2016 Jun 8.

21.

Clinical significance of acquired somatic mutations in aplastic anaemia.

Marsh JC, Mufti GJ.

Int J Hematol. 2016 Aug;104(2):159-67. doi: 10.1007/s12185-016-1972-8. Epub 2016 Mar 18. Review.

PMID:
27084249
22.

Sweet spot for cyclophosphamide: a balancing act.

Kulasekararaj AG, Marsh JC.

Lancet Haematol. 2015 Sep;2(9):e350-1. doi: 10.1016/S2352-3026(15)00158-1. Epub 2015 Sep 2. No abstract available.

PMID:
26685766
23.

Guidelines for the diagnosis and management of adult aplastic anaemia.

Killick SB, Bown N, Cavenagh J, Dokal I, Foukaneli T, Hill A, Hillmen P, Ireland R, Kulasekararaj A, Mufti G, Snowden JA, Samarasinghe S, Wood A, Marsh JC; British Society for Standards in Haematology.

Br J Haematol. 2016 Jan;172(2):187-207. doi: 10.1111/bjh.13853. Epub 2015 Nov 16. No abstract available. Erratum in: Br J Haematol. 2016 Nov;175(3):546.

PMID:
26568159
24.

Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia.

Mufti GJ, Kulasekararaj AG, Marsh JC.

N Engl J Med. 2015 Oct 22;373(17):1674-5. doi: 10.1056/NEJMc1509703. No abstract available.

PMID:
26488705
25.

Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.

Dufour C, Veys P, Carraro E, Bhatnagar N, Pillon M, Wynn R, Gibson B, Vora AJ, Steward CG, Ewins AM, Hough RE, de la Fuente J, Velangi M, Amrolia PJ, Skinner R, Bacigalupo A, Risitano AM, Socie G, Peffault de Latour R, Passweg J, Rovo A, Tichelli A, Schrezenmeier H, Hochsmann B, Bader P, van Biezen A, Aljurf MD, Kulasekararaj A, Marsh JC, Samarasinghe S.

Br J Haematol. 2015 Nov;171(4):585-94. doi: 10.1111/bjh.13614. Epub 2015 Jul 28.

PMID:
26223288
26.

Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.

Sureda A, Bader P, Cesaro S, Dreger P, Duarte RF, Dufour C, Falkenburg JH, Farge-Bancel D, Gennery A, Kröger N, Lanza F, Marsh JC, Nagler A, Peters C, Velardi A, Mohty M, Madrigal A.

Bone Marrow Transplant. 2015 Aug;50(8):1037-56. doi: 10.1038/bmt.2015.6. Epub 2015 Mar 23. Review.

PMID:
25798672
27.

Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis.

Bacigalupo A, Socié G, Hamladji RM, Aljurf M, Maschan A, Kyrcz-Krzemien S, Cybicka A, Sengelov H, Unal A, Beelen D, Locasciulli A, Dufour C, Passweg JR, Oneto R, Signori A, Marsh JC; Aplastic Anemia Working Party of the European Group for Blood Marrow Transplantation.

Haematologica. 2015 May;100(5):696-702. doi: 10.3324/haematol.2014.115345. Epub 2015 Jan 23.

28.

Involvement of the neural stem cell compartment by pediatric and adult gliomas: a retrospective review of 377 cases.

Marsh JC, Goldman S, Ziel E, Bregman C, Diaz A, Byrne R, Fangusaro J.

J Neurooncol. 2015 Mar;122(1):105-10. doi: 10.1007/s11060-014-1682-0. Epub 2014 Dec 11.

PMID:
25502962
29.

Successful treatment of aplastic anaemia associated with HIV infection with eltrombopag: implications for a possible immunomodulatory role.

Bart-Smith EE, Kordasti S, Kulasekararaj AG, Richardson D, Mufti GJ, Marsh JC.

AIDS. 2014 Nov 28;28(18):2786-8. doi: 10.1097/QAD.0000000000000504.

PMID:
25333665
30.

Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome.

Kulasekararaj AG, Jiang J, Smith AE, Mohamedali AM, Mian S, Gandhi S, Gaken J, Czepulkowski B, Marsh JC, Mufti GJ.

Blood. 2014 Oct 23;124(17):2698-704. doi: 10.1182/blood-2014-05-574889. Epub 2014 Aug 18.

31.

Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia.

Clay J, Kulasekararaj AG, Potter V, Grimaldi F, McLornan D, Raj K, de Lavallade H, Kenyon M, Pagliuca A, Mufti GJ, Marsh JC.

Biol Blood Marrow Transplant. 2014 Nov;20(11):1711-6. doi: 10.1016/j.bbmt.2014.06.028. Epub 2014 Jul 10.

32.

Eltrombopag: a stem cell cookie?

Marsh JC, Mufti GJ.

Blood. 2014 Mar 20;123(12):1774-5. doi: 10.1182/blood-2014-02-553404. No abstract available.

PMID:
24652959
33.

Gender disparities in utilization and outcome of comprehensive substance abuse treatment among racial/ethnic groups.

Guerrero EG, Marsh JC, Cao D, Shin HC, Andrews C.

J Subst Abuse Treat. 2014 May-Jun;46(5):584-91. doi: 10.1016/j.jsat.2013.12.008. Epub 2013 Dec 21.

34.

Management of the refractory aplastic anemia patient: what are the options?

Marsh JC, Kulasekararaj AG.

Hematology Am Soc Hematol Educ Program. 2013;2013:87-94. doi: 10.1182/asheducation-2013.1.87. Review.

PMID:
24319168
35.

Long-term outcomes of alemtuzumab-based reduced-intensity conditioned hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myelogenous leukemia secondary to myelodysplastic syndrome.

Potter VT, Krishnamurthy P, Barber LD, Lim Z, Kenyon M, Ireland RM, de Lavallade H, Dhouri A, Marsh JC, Marcus R, Devereux S, Ho A, Pagliuca A, Mufti GJ.

Biol Blood Marrow Transplant. 2014 Jan;20(1):111-7. doi: 10.1016/j.bbmt.2013.10.021. Epub 2013 Nov 8.

36.

Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience.

Peffault de Latour R, Porcher R, Dalle JH, Aljurf M, Korthof ET, Svahn J, Willemze R, Barrenetxea C, Mialou V, Soulier J, Ayas M, Oneto R, Bacigalupo A, Marsh JC, Peters C, Socie G, Dufour C; FA Committee of the Severe Aplastic Anemia Working Party; Pediatric Working Party of the European Group for Blood and Marrow Transplantation.

Blood. 2013 Dec 19;122(26):4279-86. doi: 10.1182/blood-2013-01-479733. Epub 2013 Oct 21.

PMID:
24144640
37.

Haematopoietic stem cell transplantation for acquired aplastic anaemia.

Young ME, Potter V, Kulasekararaj AG, Mufti GJ, Marsh JC.

Curr Opin Hematol. 2013 Nov;20(6):515-20. doi: 10.1097/MOH.0b013e328365af83. Review.

PMID:
24104412
38.

Management of the refractory aplastic anemia patient: what are the options?

Marsh JC, Kulasekararaj AG.

Blood. 2013 Nov 21;122(22):3561-7. doi: 10.1182/blood-2013-05-498279. Epub 2013 Sep 19. Review.

PMID:
24052548
39.

Disparities in Latino substance use, service use, and treatment: implications for culturally and evidence-based interventions under health care reform.

Guerrero EG, Marsh JC, Khachikian T, Amaro H, Vega WA.

Drug Alcohol Depend. 2013 Dec 15;133(3):805-13. doi: 10.1016/j.drugalcdep.2013.07.027. Epub 2013 Aug 2. Review.

PMID:
23953657
40.

Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation.

Marsh JC, Pearce RM, Koh MB, Lim Z, Pagliuca A, Mufti GJ, Perry J, Snowden JA, Vora AJ, Wynn RT, Russell N, Gibson B, Gilleece M, Milligan D, Veys P, Samarasinghe S, McMullin M, Kirkland K, Cook G; British Society for Blood and Marrow Transplantation, Clinical Trials Committee.

Bone Marrow Transplant. 2014 Jan;49(1):42-8. doi: 10.1038/bmt.2013.115. Epub 2013 Aug 5.

PMID:
23912664
42.

Bilateral retinal vasculopathy associated with autosomal dominant dyskeratosis congenita.

Vaz-Pereira S, Pacheco PA, Gandhi S, Kulasekararaj AG, Marsh JC, Pal B, Mufti GJ.

Eur J Ophthalmol. 2013 Sep-Oct;23(5):772-5. doi: 10.5301/ejo.5000297. Epub 2013 May 3.

PMID:
23661544
43.

Allogeneic stem cell transplantation using alemtuzumab-containing regimens in severe aplastic anemia.

Gandhi S, Kulasekararaj AG, Mufti GJ, Marsh JC.

Int J Hematol. 2013 May;97(5):573-80. doi: 10.1007/s12185-013-1333-9. Epub 2013 Apr 30. Review.

PMID:
23632948
44.

Disparities in completion of substance abuse treatment between and within racial and ethnic groups.

Guerrero EG, Marsh JC, Duan L, Oh C, Perron B, Lee B.

Health Serv Res. 2013 Aug;48(4):1450-67. doi: 10.1111/1475-6773.12031. Epub 2013 Jan 27.

45.

Current status of immunotherapy and gene therapy for high-grade gliomas.

Marsh JC, Goldfarb J, Shafman TD, Diaz AZ.

Cancer Control. 2013 Jan;20(1):43-8. Review.

PMID:
23302906
46.

TP53 mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis.

Kulasekararaj AG, Smith AE, Mian SA, Mohamedali AM, Krishnamurthy P, Lea NC, Gäken J, Pennaneach C, Ireland R, Czepulkowski B, Pomplun S, Marsh JC, Mufti GJ.

Br J Haematol. 2013 Mar;160(5):660-72. doi: 10.1111/bjh.12203. Epub 2013 Jan 9.

PMID:
23297687
47.

Outcome of donor lymphocyte infusion after T cell-depleted allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndromes.

Krishnamurthy P, Potter VT, Barber LD, Kulasekararaj AG, Lim ZY, Pearce RM, de Lavallade H, Kenyon M, Ireland RM, Marsh JC, Devereux S, Pagliuca A, Mufti GJ.

Biol Blood Marrow Transplant. 2013 Apr;19(4):562-8. doi: 10.1016/j.bbmt.2012.12.013. Epub 2012 Dec 21.

48.

Unrelated donor search and unrelated donor transplantation in the adult aplastic anaemia patient aged 18-40 years without an HLA-identical sibling and failing immunosuppression.

Bacigalupo A, Marsh JC.

Bone Marrow Transplant. 2013 Feb;48(2):198-200. doi: 10.1038/bmt.2012.233. Epub 2012 Nov 26. Review.

PMID:
23178545
49.

Treatment of aplastic anaemia in elderly patients aged >60 years.

Tichelli A, Marsh JC.

Bone Marrow Transplant. 2013 Feb;48(2):180-2. doi: 10.1038/bmt.2012.224. Epub 2012 Nov 26. Review.

PMID:
23178542
50.

Client and program characteristics associated with wait time to substance abuse treatment entry.

Andrews CM, Shin HC, Marsh JC, Cao D.

Am J Drug Alcohol Abuse. 2013 Jan;39(1):61-8. doi: 10.3109/00952990.2012.694515. Epub 2012 Jul 11.

PMID:
22783953

Supplemental Content

Loading ...
Support Center